Miller Applauds House Passage of VA Opioid Legislation
Today the U.S. House of Representatives passed H.R. 4063, the Jason Simcakoski Promoting Responsible Opioid Management and Incorporating Scientific Expertise (PROMISE) Act.
The bill would improve Department of Veterans Affairs opioid safety measures by directing all department hospitals to designate pain management teams, ensuring employees that prescribe opioid drugs receive proper training in pain management and safe opioid prescribing practices, and standardizing safe opioid utilization and tracking practices across the system. The bill also increases accountability by requiring the directors of each VA hospital to certify employees have received the proper training in prescribing opioids. Finally, recognizing the need to ensure safe transition between the Department of Defense and VA, the bill requires an update of joint VA/DoD clinical practice guidelines.
The PROMISE Act is named in honor of Marine Corps veteran Jason Simcakoski, who died of mixed drug toxicity while he was an inpatient at the Tomah, Wis., VA Medical Center. A VA investigation found that hospital staff improperly prescribed his medications.
H.R. 4063 now awaits consideration by the Senate. Following House passage of the bill, Chairman Miller released the below statement.
“A bag of pills is simply not a solution to a veteran’s health care needs. That’s why we must act to reduce VA’s reliance on prescription painkillers and ensure that in instances they are prescribed, VA is doing so safely. Veterans and families shouldn’t have to suffer like Jason Simcakoski and his loved ones have, and if the PROMISE Act becomes law, it will help ensure they won’t.” – Rep. Jeff Miller, Chairman, House Committee on Veterans’ Affairs